Business Standard

Over 75% pharma stocks eye breakout; most may see up to 15% upside

Barring, Pfizer, Gland Pharma, and Laurus Labs, all other constituents of Nifty Pharm Index trade over the 200-day simple moving average (SMA),

pharma, medicine, drugs
Web Exclusive Premium

Pharma stocks are poised for next upside

Avdhut Bagkar Mumbai

Listen to This Article

Nifty Pharm index clinched to a new historic peak in the recent sessions, triggering fresh breakouts in several of its constituents. Reddy laboratories, Torrent Pharmaceuticals, Zydus Lifesciences ,Sun Pharmaceutical Industries, Alkem Laboratories, Cipla, and Abbott India firmly claimed new territories hitting fresh all-time highs.

On Monday, shares of Laurus Labs soared over 6 per cent, while Gland Pharma and IPCA Laboratories gained 3 per cent each. Similarly, NATCO Pharma, Lupin and Glaxosmithkline Pharmaceuticals advanced between 1 per cent to 2 per cent in a session where benchmark indices opened on a sluggish bias.

The Pharma Index has surged over 18

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 31 2023 | 11:17 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com